The cost of hepatitis C and the cost-effectiveness of its prevention

By Shiell A.   Law M.G.  

Health Policy, Vol. 58, Iss. 2, 2001-11 ,pp. : 121-131

Elsevier

Access to resources Recommend Favorite

Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis

By Mueller Dirk  

Applied Health Economics and Health Policy, Vol. 9, Iss. 4, 2011-07 ,pp. : 259-273

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection

By Pechevis M.   Khoshnood B.   Buteau L.   Durand I.   Piquard Y.   Lafuma A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3556-3564

Elsevier

Access to resources Recommend Favorite

Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD)

By Godemann F.   Butter C.   Lampe F.   Linden M.   Werner S.   Behrens S.  

Quality of Life Research, Vol. 13, Iss. 2, 2004-03 ,pp. : 411-416

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease?

By Lindholm L.   Hallgren C.-G.   Boman K.   Markgren K.   Weinehall L.   Ogren J.-E.  

Health Policy, Vol. 48, Iss. 3, 1999-08 ,pp. : 155-170

Elsevier

Access to resources Recommend Favorite